Ulcerative Colitis Patients Resistant to Treatment May Find Golimumab a Viable Therapeutic Option
IBD News, News, Ulcerative colitis
Golimumab (symponi) is the latest addition to TNF-α blocking drugs for inflammatory bowel diseases (IBD) such as ulcerative colitis (UC). A summary of all available safety and efficacy data on the ... Read more